Literature DB >> 15648076

Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells.

Samila Siavoshian1, Jean Daniel Abraham, Christine Thumann, Marie Paule Kieny, Catherine Schuster.   

Abstract

Although reasons for hepatitis C virus (HCV) persistence are still unknown, specific cellular immune responses appear to influence the pathogenesis and outcome of the infection. Apoptosis of cells infected by viruses may appear suicidal to the viruses that induce programmed cell death of its host. However, apoptosis has been suggested to be a response to virus infection as a mean of facilitating virus dissemination. Annexin V-propidium iodide staining and DNA fragmentation, were used to show that expression of the core, NS3, NS5A, or NS5B protein induces apoptosis in mature dendritic cells. In addition, immunoblotting was used to demonstrate that expression level of p21waf1/cip1 protein decreased in cells expressing one of these HCV proteins. No expression of p53 could be detected and expression of Akt was independent of HCV proteins expression. These results suggest that the effect of these HCV proteins on HCV associated pathogenesis may be linked (at least partially) to its ability to modulate apoptosis pathways in mature dendritic cells. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15648076     DOI: 10.1002/jmv.20283

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

1.  Do DCs influence the antiviral effect of interferon/ribavirin by changing their profile during the therapy?

Authors:  Hiroki Takahashi; Mikio Zeniya
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Construction of eukaryotic expression plasmid containing HCV NS3 segment and protein expression in human HL-7702 hepatocytes.

Authors:  Jun-Wu Li; Ke Li; Jing Jiang; Xiao-Liang Xu; Ze-Qi Huang
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 3.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

Review 4.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

5.  Hepatitis C virus core protein activates autophagy through EIF2AK3 and ATF6 UPR pathway-mediated MAP1LC3B and ATG12 expression.

Authors:  Ji Wang; Rongyan Kang; He Huang; Xueyan Xi; Bei Wang; Jianwei Wang; Zhendong Zhao
Journal:  Autophagy       Date:  2014-02-20       Impact factor: 16.016

Review 6.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 7.  Hepatitis C virus infection and apoptosis.

Authors:  Richard Fischer; Thomas Baumert; Hubert-E Blum
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

8.  Bioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in mice.

Authors:  Juan Du; Fang Zhao; Yong Zhou; Hu Yan; Xiang-guo Duan; Sheng-qiang Liang; Ying-li Wang; Qiu-xia Fu; Xiao-hui Wang; Jian-chun Peng; Lin-sheng Zhan
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

9.  Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway.

Authors:  Lin Deng; Tetsuya Adachi; Kikumi Kitayama; Yasuaki Bungyoku; Sohei Kitazawa; Satoshi Ishido; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  Inhibition of hepatitis C virus (HCV) core protein- induced cell growth by non-structural protein 4A (NS4A) is mediated by mitochondrial dysregulation.

Authors:  Denis Selimović; Mohamed Hassan
Journal:  Bosn J Basic Med Sci       Date:  2008-02       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.